Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00413296 · ClinicalTrials.gov registry record · Phase 2
Levetiracetam in Post-Traumatic Stress Disorder
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00413296 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 16 participants.
The verdict
NCT00413296, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the short-term efficacy and safety of levetiracetam in post-traumatic stress disorder (PTSD) and to evaluate continuation effects of levetiracetam in preventing PTSD relapse. The hypothesis is that levetiracetam will be safe and effective in preventing relapse of PTSD.
Interventions
- DRUG Placebo
- DRUG levetiracetam
- DRUG Levetriracetam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00413296
The ClinicalTrials.gov registry entry for NCT00413296 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00413296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00413296 about?
NCT00413296 is a clinical study titled "Levetiracetam in Post-Traumatic Stress Disorder". The purpose of this study is to evaluate the short-term efficacy and safety of levetiracetam in post-traumatic stress disorder (PTSD) and to evaluate continuation effects of levetiracetam in preventing PTSD relapse. The hypothesis is that levetiracetam will be safe and effective in preventing relaps...
What is the current status of trial NCT00413296?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2005-11. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00413296?
The interventions under investigation include: Placebo (DRUG), levetiracetam (DRUG), Levetriracetam (DRUG).
Who is sponsoring clinical trial NCT00413296?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.